Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Cacng3em1/Cya
Common Name:
Cacng3-KO
Product ID:
S-KO-10509
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cacng3-KO
Strain ID
KOCMP-54376-Cacng3-B6J-VA
Gene Name
Cacng3
Product ID
S-KO-10509
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
54376
Modification
Conventional knockout
Chromosome
7
Phenotype
MGI:1859165
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cacng3em1/Cya mice (Catalog S-KO-10509) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000084615
NCBI RefSeq
NM_019430
Target Region
Exon 1
Size of Effective Region
~2.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Cacng3, without common aliases mentioned in the provided references, is likely related to synaptic transmission based on functional annotation and pathway enrichment analysis of differently expressed genes, suggesting its importance in neural-related biological processes [1]. It is also associated with voltage-gated calcium channels, which are crucial in neuronal electrical activity [3,6,7]. Genetic models can be valuable in further exploring its functions.

In glioma, Cacng3 is expressed at low levels in the tumor group, and patients with low Cacng3 expression have shorter overall survival. Its expression is negatively associated with glioma grades, and it can serve as a biomarker for the mesenchymal molecular subtype. Additionally, temozolomide, a glioma treatment drug, increases Cacng3 expression in a dose-and time-dependent manner [1].

In childhood absence epilepsy, linkage and association analysis support Cacng3 as a susceptibility locus in a subset of patients, though no putative causal variants were identified in coding exons [3].

In age-related macular degeneration, evidence from linkage and association studies suggests Cacng3 is a candidate risk gene within the 16p12 linkage peak [4].

In pancreatic cancer, Cacng3 is among the genes with negative regulation identified by machine-learning algorithms, and its role in the disease pathogenesis is indicated [2].

In autism spectrum disorder (ASD) iPSC-derived neurons with NRXN1α+/- deletion, Cacng3 is among the genes with significant up-regulation of glutamatergic synapse and ion channels/transporter activity, likely contributing to increased neuronal excitability [5].

In conclusion, Cacng3 plays significant roles in multiple disease conditions. In glioma, it is related to prognosis and can potentially be a biomarker and therapeutic target. In epilepsy, it may contribute to susceptibility. In age-related macular degeneration, it could be a risk gene. In pancreatic cancer, it is involved in disease-related regulation, and in ASD-related neuronal excitability, it has a part to play. These findings from various research models, including in-vivo-like studies in human patients, help understand the complex functions of Cacng3 in different biological processes and disease mechanisms.

References:

1. Shan, Enfang, Cao, Yi-Nan, Zhang, Yang, Zhi, Tongle, Li, Xianwen. 2023. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma. In BMC cancer, 23, 846. doi:10.1186/s12885-023-10896-1. https://pubmed.ncbi.nlm.nih.gov/37697240/

2. Khojasteh-Leylakoohi, Fatemeh, Mohit, Reza, Khalili-Tanha, Nima, Batra, Jyotsna, Avan, Amir. 2023. Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. In Scientific reports, 13, 16678. doi:10.1038/s41598-023-42928-y. https://pubmed.ncbi.nlm.nih.gov/37794108/

3. Everett, Kate V, Chioza, Barry, Aicardi, Jean, Rees, Michele, Gardiner, Mark. 2007. Linkage and association analysis of CACNG3 in childhood absence epilepsy. In European journal of human genetics : EJHG, 15, 463-72. doi:. https://pubmed.ncbi.nlm.nih.gov/17264864/

4. Spencer, Kylee L, Olson, Lana M, Schnetz-Boutaud, Nathalie, Pericak-Vance, Margaret A, Haines, Jonathan L. 2011. Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility. In Investigative ophthalmology & visual science, 52, 1748-54. doi:10.1167/iovs.09-5112. https://pubmed.ncbi.nlm.nih.gov/21169531/

5. Avazzadeh, Sahar, Quinlan, Leo R, Reilly, Jamie, Shen, Sanbing, Gallagher, Louise. 2021. NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons. In BMC neuroscience, 22, 56. doi:10.1186/s12868-021-00661-0. https://pubmed.ncbi.nlm.nih.gov/34525970/

6. Yalçın, Ozlem. 2011. Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies. In Seizure, 21, 79-86. doi:10.1016/j.seizure.2011.12.002. https://pubmed.ncbi.nlm.nih.gov/22206818/

7. Robinson, Robert, Taske, Nichole, Sander, Thomas, Rees, Michele, Gardiner, R Mark. . Linkage analysis between childhood absence epilepsy and genes encoding GABAA and GABAB receptors, voltage-dependent calcium channels, and the ECA1 region on chromosome 8q. In Epilepsy research, 48, 169-79. doi:. https://pubmed.ncbi.nlm.nih.gov/11904235/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest